FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hetero Labs Limited Unit V Famciclovir Tablets Recall

Famciclovir Tablets, 500 mg, 30-count bottles, Rx Only, Manufactured For: Camber Pharma…

Hetero Labs Limited Unit V

Risk level
Class II
Reported by FDA
Feb 21, 2018
Recall ID
D-0415-2018
Check your lot numberHow we source this data

Summary

Hetero Labs Limited Unit V recalled Famciclovir Tablets starting Dec 22, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0415-2018 on Feb 21, 2018. Reason: Temperature Abuse: Complaints of tablets being wet and stuck together with tablet coating peeled and disintegrated as a result of prolonged exposure to high temp during distribution. Status: Terminated.

Why it was recalled

Temperature Abuse: Complaints of tablets being wet and stuck together with tablet coating peeled and disintegrated as a result of prolonged exposure to high temp during distribution.

Product description

Famciclovir Tablets, 500 mg, 30-count bottles, Rx Only, Manufactured For: Camber Pharmaceuticals. Inc. Piscataway, NJ 08854 By: HETERO, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar-509 301, India. NDC 31722-708-30

Lot numbers, UPCs & expiration codes

Lot # FMC17039, Exp 07/2019.

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0415-2018
Classification
Class II
Status
Terminated
Recall initiated
Dec 22, 2017
FDA report date
Feb 21, 2018
Quantity
8,436 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Hetero Labs Limited Unit V

Original FDA data

Every field from FDA enforcement report D-0415-2018, exactly as published.

Show all FDA fields
City
Jadcherla Mandal, Mahaboob Nagar
Status
Terminated
Country
India
Event ID
78811
Address
Unit V (SEZ Unit I in APIIC SEZ)
Address (line 2)
Surv. No. 439-441, 458, Polepally Vill.
Code information
Lot # FMC17039, Exp 07/2019.
Report date
Feb 21, 2018
Product type
Drugs
Recall number
D-0415-2018
Classification
Class II
Recalling firm
Hetero Labs Limited Unit V
Product quantity
8,436 bottles
Termination date
Feb 5, 2020
Reason for recall
Temperature Abuse: Complaints of tablets being wet and stuck together with tablet coating peeled and disintegrated as a result of prolonged exposure to high temp during distribution.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Famciclovir Tablets, 500 mg, 30-count bottles, Rx Only, Manufactured For: Camber Pharmaceuticals. Inc. Piscataway, NJ 08854 By: HETERO, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar-509 301, India. NDC 31722-708-30
Distribution pattern
Nationwide in the USA.
Recall initiation date
Dec 22, 2017
Initial firm notification
Letter
Center classification date
Feb 15, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0415-2018, published Feb 21, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls